Abstract

Staphylococcus aureus (Sa) is the leading cause of a variety of bacterial infections ranging from superficial skin infections to invasive and life threatening diseases such as septic bacteremia, necrotizing pneumonia, and endocarditis. The success of Sa as a human pathogen is contributed to its ability to adapt to different environments by changing expression, production, or secretion of virulence factors. Although Sa immune evasion is well-studied, the regulation of virulence factors under different nutrient and growth conditions is still not well understood. Here, we used label-free quantitative mass spectrometry to quantify and compare the Sa exoproteins (i.e. exoproteomes) of master regulator mutants or established reference strains. Different environmental conditions were addressed by growing the bacteria in rich or minimal media at different phases of growth. We observed clear differences in the composition of the exoproteomes depending on the genetic background or growth conditions. The relative abundance of cytotoxins determined in our study correlated well with differences in cytotoxicity measured by lysis of human neutrophils. Our findings demonstrate that label-free quantitative mass spectrometry is a versatile tool for predicting the virulence of bacterial strains and highlights the importance of the experimental design for in vitro studies. Furthermore, the results indicate that label-free proteomics can be used to cluster isolates into groups with similar virulence properties, highlighting the power of label-free quantitative mass spectrometry to distinguish Sa strains.

Highlights

  • Staphylococcus aureus (Sa) asymptomatic colonization of the nares, skin or gastrointestinal tract is detected in approximately 30% of humans [1,2]

  • Bacterial virulence is dependent on its environment and genetic background

  • To better understand virulence changes associated with environmental and strain variation, we cataloged the changes in the Sa exoproteome using label-free quantitative proteomics of the representative USA300, strain LAC (WT), and isogenic mutants (Δrot, Δagr, and Δsae) grown to early stationary phase in nutrient rich or minimal media

Read more

Summary

Introduction

Staphylococcus aureus (Sa) asymptomatic colonization of the nares, skin or gastrointestinal tract is detected in approximately 30% of humans [1,2]. Sa is responsible for a variety of diseases ranging from skin and soft tissue infections to invasive diseases such as bacteremia, necrotizing pneumonia, and infective endocarditis [3,4]. How Sa switches its lifestyle from a commensal bacterium to a dangerous human pathogen is not well understood. Of particular concern is the emergence of difficult to treat, community-associated methicillin-resistant Sa (CAMRSA) that began in the 1990s. The rise of CA-MRSA indicates that MRSA strains evolved from a traditionally nosocomial pathogen to a pathogen that causes disease in healthy individuals with no healthcare associated risk factors [3,5]. The most successful CA-MRSA in the United States of America is the USA300 lineage [3,4]

Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call